Clinical Trial

A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
A Phase 2a Study of Foralumab Nasal in Patients with Multiple System Atrophy (MSA)
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-06; most recent amendment 2026-06-08.
Status change: Not Yet Recruiting → Recruiting 2025-09-18
Trial Details
NCT Number NCT06868628
Lead Sponsor Tiziana Life Sciences LTD
Conditions Multiple System Atrophy
Enrollment 5 participants
Start Date 2025-05-19
Primary Completion 2027-04-01 (estimated)
Study Completion 2027-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-10